Eileen Bauer

Pediatrics and Genetics — United States

Medicine · Health Sciences

20h-index2.5kcitations39works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pulmonary Hypertension Research and Treatments(15), Nitric Oxide and Endothelin Effects(10), Virus-based gene therapy research(6), Advanced Glycation End Products research(5), Renin-Angiotensin System Studies(3)

Publications39 total

Targeting Pulmonary Endothelial Hemoglobin α Improves Nitric Oxide Signaling and Reverses Pulmonary Artery Endothelial Dysfunction
American Journal of Respiratory Cell and Molecular Biology·2017· 29 citedOpen Access
Schizophrenia interactome with 504 novel protein–protein interactions
Schizophrenia·2016· 74 citedOpen Access
The Role of HMGB1 in Cardiovascular Biology: Danger Signals
Antioxidants and Redox Signaling·2015· 75 cited
The role of HMGB1's critical cysteines are explored in human monocytes (CAM1P.151)
The Journal of Immunology·2015
The HIV Protease Inhibitor Saquinavir Inhibits HMGBl-Driven Inflammation by Targeting the Interaction of Cathepsin V with TLR4/MyD88
Molecular Medicine·2015· 20 citedOpen Access
Pharmakotherapie von gesetzlich und privat versicherten Patienten mit Diabetes mellitus Typ 2 in der Primärversorgung mit DPP-4-Inhibitoren und den GLP-1-Agonisten
Zeitschrift für Palliativmedizin·2014
Recombinant Human Interferon Alpha 2b Prevents and Reverses Experimental Pulmonary Hypertension
PLoS ONE·2014· 19 citedOpen Access
Genetic Deletion of Toll-Like Receptor 4 on Platelets Attenuates Experimental Pulmonary Hypertension
Circulation Research·2014· 63 citedOpen Access
Thrombospondin-1 Stimulates Macrophage Reactive Oxygen Species Generation via CD47: a Novel Signaling Event in Atherosclerosis
Free Radical Biology and Medicine·2013· 1 cited
Successful immunotherapy with interleukin 2 for hypoxia-induced pulmonary hypertension (P3371)
The Journal of Immunology·2013
P1
Nitric Oxide·2013
High Mobility Group Box 1 Contributes to the Pathogenesis of Experimental Pulmonary Hypertension via Activation of Toll-like Receptor 4
Molecular Medicine·2012· 97 citedOpen Access
High Mobility Group Box 1 Inhibits Human Pulmonary Artery Endothelial Cell Migration via a Toll-like Receptor 4- and Interferon Response Factor 3-dependent Mechanism(s)
Journal of Biological Chemistry·2012· 55 citedOpen Access
A Novel Role For Interferon Response Factor 3 And Interferon Alpha In The Development Of Pulmonary Hypertension
2012
Chronic hypoxia induces right heart failure in caveolin-1−/− mice
American Journal of Physiology-Heart and Circulatory Physiology·2012· 37 citedOpen Access
ANDROGEN SUPPLEMENTATION IMPROVES RIGHT VENTRICULAR SYSTOLIC FUNCTION IN A CHRONIC HYPOXIA MODEL
Journal of the American College of Cardiology·2012
Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1
Cardiovascular Research·2012· 84 citedOpen Access
Complement C3 Deficiency Attenuates Chronic Hypoxia-Induced Pulmonary Hypertension in Mice
PLoS ONE·2011· 65 citedOpen Access
Bone Morphogenetic Protein Receptor II Is a Novel Mediator of Endothelial Nitric-oxide Synthase Activation
Journal of Biological Chemistry·2011· 85 citedOpen Access
HMGB1, An Early Mediator Of Innate Immunity, Contributes To Pulmonary Endothelial Dysfunction Presenting A New Target In The Study Of Pulmonary Hypertension
2011
page 1 of 2Next →

Frequent Co-authors

Philip M. Bauer(14), Timothy R. Billiar(6), Jorge R. Barrio(5), Meera Iyer(5), Mohammad Namavari(5), Nagichettiar Satyamurthy(5), Harvey R. Herschman(5), Hunter C. Champion(5), Sanjiv S. Gambhir(4), Michael E. Phelps(4), Han Zheng(4), Jeffrey S. Isenberg(4), Bruce R. Pitt(4), Claudette M. St. Croix(4), Gábor Csányi(3), Patrick J. Pagano(3), Jeff S. Isenberg(3), Richard A. Shapiro(3), Suzy Comhair(3), Serpil C. Erzurum(3)